Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Gyre Therapeutics Inc
Swot
Gyre Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Gyre Therapeutics Inc has 4 Strengths, 18 Weaknesses, 1 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(4)
Weakness
(18)
Opportunity
(1)
Threats
(2)
Others
(0)
Annual Profit Growth higher than Sector Profit Growth
Relative Outperformance versus Industry over 1 Week
Companies with Low Debt
Increasing Revenue every quarter for the past 2 quarters
PEG greater than Industry PEG
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
High PE (PE > 40)
Low DVM Stocks - Stocks to Exercise Caution On
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Risky Value (DVM)
Low durability companies
Highest fall from 52 Week High
Top Losers
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
Declining profits every quarter for the past 3 quarters
Profit to Loss Companies
RSI indicating price weakness
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
Institutions increasing their shareholding
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter
